文献速递免疫规划卫生政策与健康促进

治理至关重要:探讨治理对54个非洲国家常规免疫接种绩效的影响:基于线性混合模型的10年(2012-2021年)分析

Governance matters: Exploring the impact of governance on routine immunization performance in 54 African countries: A 10-year (2012-2021) analysis using linear mixed models.
PubMed 文献 · Vaccine · 2024-09-11

该生态学研究利用WHO/UNICEF国家免疫覆盖率估计和易卜拉欣非洲治理指数,采用线性混合模型分析2012至2021年54个非洲国家治理与三种疫苗常规免疫覆盖率的关系。结果显示IIAG总分每增加1分,DTPCV1、DTPCV3和MCV1覆盖率年均分别增加0.64、0.74和0.60个百分点(95%CI均不跨0),提示国家治理可能是免疫绩效的重要决定因素。

要点

  • 54个非洲国家中32国(59.3%)免疫覆盖率总体下降,16国(29.6%)显著下降(P<0.05)。
  • IIAG总分每增1分,DTPCV1、DTPCV3、MCV1覆盖率年均分别增加0.64、0.74、0.60个百分点。
  • 作者认为治理可能是免疫绩效的重要决定因素,免疫相关方或需据此调整对各国的绩效预期。

核心结论

  • 国家治理可能是免疫绩效的重要决定因素,或可解释观察到的免疫绩效停滞或下降以及免疫规划对外部冲击的脆弱性。
  • 作者认为免疫行动者、资助者及其他利益相关方或需据此调整对各国的免疫绩效预期。

研究设计与样本

  • 生态学研究,利用公开数据集WHO/UNICEF国家免疫覆盖率估计和易卜拉欣非洲治理指数(IIAG)。
  • 分析54个非洲国家2012至2021年常规免疫绩效趋势,采用线性混合模型评估治理对免疫覆盖率的影响,聚焦扩大免疫规划提供的三种疫苗(DTPCV1、DTPCV3、MCV1)。

主要发现

  • 54个非洲国家中32国(59.3%)免疫覆盖率总体下降(覆盖率随时间变化斜率<0),其中16国(29.6%)显著下降(斜率显著异于零,P<0.05)。
  • DTPCV3覆盖率31国(57.4%)下降,其中12国(22.2%)显著下降。
  • MCV1覆盖率32国(59.2%)下降,其中17国(31.5%)显著下降。
  • 三种抗原中IIAG总分均与免疫覆盖率随时间呈正相关:IIAG总分每增加1分,DTPCV1覆盖率年均增加0.64个百分点(95%CI:0.35-0.93),DTPCV3年均增加0.74个百分点(95%CI:0.42-1.07),MCV1年均增加0.60个百分点(95%CI:0.30-0.91)。
  • IIAG总分比研究期间观测平均值高1分的非洲国家,其DTPCV1、DTPCV3、MCV1覆盖率将分别比2021年水平高6.4%、7.4%、6.0%。

临床怎么用

  • 原文未据此给出推荐;作者认为免疫行动者、资助者及其他利益相关方或需调整对各国的免疫绩效预期。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immunization coverage across numerous African nations has, unfortunately, shown little improvement and, in some cases, has even decreased over the past decade, leaving millions of children vulnerable to vaccine-preventable diseases. While efforts to improve immunization performance have primarily focused on the health system, effective delivery of immunization services is intricately linked to a country's governance, which, in this context, reflects a government's ability to provide comprehensive services to its citizens. This study investigated the relationship between governance, measured using the Mo Ibrahim Index for African Governance, and the trajectory of immunization coverage for three vaccines in 54 African countries from 2012 to 2021. METHODS: We conducted an ecological study utilizing publicly available datasets, the WHO/UNICEF estimates of National Immunization Coverage and the Ibrahim Index of African Governance score (IIAG). We described the trends in routine immunization performance, evaluated and assessed the impact of governance on immunization coverage across 54 African countries for the period 2012 to 2021, using linear mixed models and focusing on three vaccines provided through the Expanded Program on Immunization (DTPCV1, DTPCV3, and MCV1). RESULTS: Among the 54 African countries studied, 32 (59.3 %) witnessed an overall decrease (slope of change in immunization coverage over time < 0) in immunization coverage, with 16 (29.6 %) experiencing a significant decline (slope of change significantly different from zero (P < 0.05)) in coverage. For DTPCV3, 31 countries (57.4 %) demonstrated a decline in coverage, with 12 (22.2 %) being significant declines. Thirty-two countries (59.2 %) reported a decrease in MCV1 coverage over the analysis period, with 17 (31.5 %) significant. Across all three antigens, the IIAG overall score was positively associated with immunization coverage over time. One unit increase in the IIAG score correlated with an average annual increase of 0.64 (95 % CI: 0.35-0.93) percentage points in DTPCV1 coverage, 0.74 percentage points (95 % CI: 0.42-1.07) in DTPCV3 coverage, and 0.60 (95 % CI: 0.30-0.91) percentage points in MCV1 coverage. These findings suggest that an African country with an average IIAG score just one unit higher than their observed average value over the study period, would have achieved a 6.4 %, 7.4 %, and 6.0 % coverage for DTPCV1, DTPCV3, and MCV1, respectively, above its 2021 coverage levels. CONCLUSION: The Expanded Program on Immunization aspires to reach all eligible populations with life-saving vaccines, regardless of the context. We found that country governance may be an important determinant of immunization performance, potentially explaining the observed stagnation or decline in immunization performance and the heightened vulnerability of immunization programs to external shocks. Understanding the nexus between governance and service delivery suggests that immunization actors, funders, and other stakeholders may need to adjust their expectations of countries' immunization performance accordingly.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kamadjeu R, Wyka K, Kelvin EA, et al. Governance matters: Exploring the impact of governance on routine immunization performance in 54 African countries: A 10-year (2012-2021) analysis using linear mixed models. Vaccine. 2024. PMID: 39265457. doi:10.1016/j.vaccine.2024.126293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。